Dobutamine Versus Milrinone After Subarachnoid Hemorrhage
Overview
Authors
Affiliations
Objective: Neurogenic stunned myocardium is a well-recognized complication of subarachnoid hemorrhage. Dobutamine and milrinone are both used for neurogenic stunned myocardium, but there are few data comparing them after subarachnoid hemorrhage.
Methods: We compared the physiological dose response of dobutamine and milrinone in patients with subarachnoid hemorrhage requiring a pulmonary artery catheter. We located 11 patients who received either inotrope. Physiological data were fitted to a mixed model accounting for drug, dose, and between-patient variation.
Results: There were 11 patients who had 152 pulmonary artery catheter measurements. Two received both inotropes (but not within 4 h of each other), 2 only milrinone, and 7 only dobutamine. The groups had similar clinical and physiological characteristics. After adjustment for vasopressin, milrinone was significantly more potent in increasing cardiac output (P <0.0001) and stroke volume (P=0.03), while decreasing vascular resistance (P <0.0001) and systolic blood pressure (P=0.008), than dobutamine.
Conclusion: These data suggest that milrinone and dobutamine should be used in different clinical situations. Milrinone may be more effective in patients with severely depressed systolic function but who have at least normal vascular resistance and blood pressure and in whom raising cardiac output is the primary goal. Dobutamine may be superior when vascular resistance or blood pressure is low.
Salvagno M, Geraldini F, Coppalini G, Robba C, Gouvea Bogossian E, Annoni F Brain Sci. 2024; 14(2).
PMID: 38391692 PMC: 10886736. DOI: 10.3390/brainsci14020117.
Updates on aneurysmal subarachnoid hemorrhage: is there anything really new?.
Marazzi T, Mendes P Arq Neuropsiquiatr. 2022; 80(5 Suppl 1):80-87.
PMID: 35976291 PMC: 9491434. DOI: 10.1590/0004-282X-ANP-2022-S101.
Effect of inotropic agents on oxygenation and cerebral perfusion in acute brain injury.
Coppalini G, Duvigneaud E, Diosdado A, Migliorino E, Schuind S, Creteur J Front Neurol. 2022; 13:963562.
PMID: 35928138 PMC: 9343780. DOI: 10.3389/fneur.2022.963562.
Clinical Treatment and Prognostic Analysis of Patients with Aneurysmal Subarachnoid Hemorrhage.
Yang X, Cheng Q, Li Y, Zheng Z, Liu J, Zhao Z J Healthc Eng. 2021; 2021:1250334.
PMID: 34900174 PMC: 8660210. DOI: 10.1155/2021/1250334.
Lin X, Zheng L World J Clin Cases. 2019; 7(21):3603-3614.
PMID: 31750344 PMC: 6854395. DOI: 10.12998/wjcc.v7.i21.3603.